跳至主要内容
临床试验/NCT07801066
NCT07801066尚未招募4 期

A Prospective, Randomized, Single-blind, Study to Assess Drowsiness, Cognition, Fall Risk, and Electroencephalographic (EEG) Dynamics Following Oral Metaxalone Tablets 640 mg (M640) Versus Metaxalone 800 mg in Healthy Participants: A Bootstrap Validation.

Primus Pharmaceuticals1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2026年9月15日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
尚未招募
入组人数
20
试验地点
1
主要终点
Change from baseline to approximately 4 hours post-dose, in mean reaction time to a stimulus as measured in milliseconds by the Reaction Time Test (RTT)

研究概览

简要总结

Health participants take a single dose, perform testing, washout for one week, take a single dose of different formulation, and perform testing for comparison of the 2 doses.

详细描述

Healthy participants will take one dose of a drug after eating a meal. When the drug is at the highest level in their blood, testing for drowsiness and the risk of falling will take place. Brain wave monitoring known as an EEG will take place throughout the testing. Participants will take a second dose of the drug with the same testing one week later.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Basic Science
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 55 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Healthy adults aged 18 to 55 years old
  • Weigh at least 120 pounds
  • Medically healthy
  • Able to sign and date informed consent form

排除标准

  • Current use of any medications known to affect the sleep-wake cycle
  • Sleep disorder diagnosis
  • Positive urine test for drugs
  • Known history of alcohol use disorder
  • Having a history of cognitive disorders, depression, schizophrenia, panic disorder, or dementia
  • Having difficulty eating high fat meal
  • Participants who are pregnant, nursing or intending to become pregnant during the period of study.
  • Blood Pressure > 160/110 or <90/50 mmHg.
  • Heart Rate >100 or < 50/ beats per minute.
  • Having a history of seizure disorder or epilepsy.

研究组 & 干预措施

Active metaxalone m640 mg

Active Comparator

One dose administered after a standard meal with testing Baseline dose to time of maximum concentration (Tmax)

干预措施: Metaxalone 640 mg (Drug)

Active metaxalone 800 mg

Active Comparator

One dose administered after a standard meal with testing Baseline dose to time of maximum concentration (Tmax)

干预措施: Metaxalone 800 MG (Drug)

结局指标

主要结局

Change from baseline to approximately 4 hours post-dose, in mean reaction time to a stimulus as measured in milliseconds by the Reaction Time Test (RTT)

时间窗: Baseline dose to four (4 ) hours post-dose

Change from baseline to approximately 4 hours post-dose of delayed response exceeding a predefined threshold >300 ms as measured by the Reaction Time Test (RTT)

时间窗: Baseline dose to approximately 4 hours post-dose

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验